Llwytho...

Molecular markers and prediction of response to immunotherapy in non-small cell lung cancer, an update

Immunotherapy represents one of the most promising therapeutic approaches in lung cancer, however 50% of lung cancer patients will not respond to this treatment, while others will have transitory or durable responses. Because side effects may be life threatening and treatment costs remain very high,...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Thorac Dis
Prif Awduron: Blons, Hélène, Garinet, Simon, Laurent-Puig, Pierre, Oudart, Jean-Baptiste
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AME Publishing Company 2019
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6353739/
https://ncbi.nlm.nih.gov/pubmed/30775025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.12.48
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!